K. Ozono et al., IDENTIFICATION OF NOVEL MISSENSE MUTATIONS (PHE310LEU AND GLY439ARG) IN A NEONATAL CASE OF HYPOPHOSPHATASIA, The Journal of clinical endocrinology and metabolism, 81(12), 1996, pp. 4458-4461
Hypophosphatasia is associated with a defect of the tissue-nonspecific
alkaline phosphatase gene. We performed a mutational analysis in a su
rviving patient diagnosed at birth as having hypophosphatasia, on the
basis of a low level of serum alkaline phosphatase (ALP) activity and
characteristic radiographical findings. She had two sisters, one of wh
om died of respiratory failure complicated by perinatal hypophosphatas
ia; the other seemed healthy, with a relatively low activity level of
ALP. The patient's parents also had low ALP activity. Sequence analysi
s of the tissue-nonspecific alkaline phosphatase gene was performed, u
sing genomic DNA and total RNA from the skin fibroblasts of the patien
t and the peripheral mononuclear cells of her parents. The conversion
of Phe to Leu at codon 310 (F310L) and Gly to Arg at 439 (G439R) were
identified in the patient. Interestingly, the reconstructive experimen
ts demonstrated that the F310L mutant exhibited an ALP activity level
65% of the normal level, whereas the mutant G439R had no activity. Mor
eover, the digestion by StuI, after a PCR using complementary DNA extr
acted from fibroblasts of the patient and lymphocytes of her father, r
evealed a relatively low messenger RNA level of F310L. These findings
suggest that the neonatal case of hypophosphatasia was associated with
compound mutations, one of which caused the loss of ALP activity and
the other of which caused a slight reduction of the ALP activity, with
a relatively low level of messenger RNA.